Okay, let's tackle this question about BIRADS score 4. First, I need to recall what BIRADS stands for. BIRADS is the Breast Imaging Reporting and Data System. It's used in mammography to categorize the likelihood of breast lesions being benign or malignant.

The question is asking what the next step is if the BIRADS score is 4. From what I remember, BIRADS categories range from 0 to 6. Category 0 means incomplete and needs additional imaging. Category 1 is normal, 2 is benign, 3 is probably benign, 4 is suspicious, 5 is highly suspicious, and 6 is known biopsy-proven malignancy.

So a BIRADS 4 is suspicious for malignancy. The next step after a BIRADS 4 is typically a biopsy. The options probably include options like biopsy, follow-up imaging, or maybe some other steps. The key is that BIRADS 4 indicates a need for tissue sampling to confirm the diagnosis.

Now, for the incorrect options. Let's say the options are A: Repeat in 6 months, B: Ultrasound only, C: Biopsy, D: MRI. Then, the correct answer is C. The other options are incorrect because BIRADS 4 isn't just monitored; a biopsy is necessary. Ultrasound might be part of the initial workup but not the next step. MRI is not the first step here.

Clinical pearl: Remember BIRADS 4 requires biopsy. The categories 0-6 each have specific management steps. BIRADS 4 has a 10-50% chance of malignancy, so biopsy is essential. Mnemonic: 4 is "suspicious," so "biopsy" is the next step.

**Core Concept**
The BIRADS (Breast Imaging Reporting and Data System) score 4 indicates suspicious imaging findings with a 10-50% malignancy risk. It mandates tissue confirmation to differentiate benign vs. malignant pathology. This system standardizes breast imaging reporting and guides management decisions.

**Why the Correct Answer is Right**
A BIRADS 4 score requires **biopsy** (e.g., core needle or excisional) to confirm malignancy. Suspicious features include irregular margins, microcalcifications, or architectural distortion. Biopsy provides histopathological diagnosis, which is critical for staging and treatment planning in suspected breast cancer.

**Why Each Wrong Option is Incorrect**
**Option A:** *Repeat imaging in 6 months* is incorrect because BIRADS 4 is not a "probably benign" category (unlike BIRADS 3). Delaying biopsy increases risk of missed malignancy.
**Option B:** *Ultrasound-guided aspiration* alone is insufficient; it provides cytology but lacks architectural detail. Core biopsy is required for definitive diagnosis.
**Option D:** *MRI* is not a first-line diagnostic tool for BIRADS 4; it’s used for staging or high-risk screening, not initial assessment.

**Clinical Pearl / High-Yield Fact**
BIRADS 4 is a red flag for malignancy. Remember: **BIRADS 4 = Biopsy Required for Informed Decision on Surgical Options**. Never follow up with observation alone in this category.

**Correct Answer: C. Biopsy**

✓ Correct Answer: C. Biopsy